Frank David 10/16/26 Frank David 10/16/26

What we’ll likely see in Merck and Moderna’s upcoming cancer vaccine data

After a skimpy press release, we’re about to get more data on an exciting cancer therapy. Here’s a balanced take on what to expect.

Frank David 1/31/25 Frank David 1/31/25

A new take on developing drugs for chronic pain

Despite a recent failure, Lilly’s master protocol trial shows a path forward in chronic pain R&D.

Frank David 11/30/22 Frank David 11/30/22

Learn the classic signs of spin and misdirection in biotech PR about clinical trial results.

Frank David 2/15/22 Frank David 2/15/22

A framework to more methodically assess clinical development probability of success (POS).

Frank David 3/14/21 Frank David 3/14/21

Learn to analyze biotech trials like a pro!